Effect of donkey milk on the new corona virus infectio
Not Applicable
Recruiting
- Conditions
- COVID-19.COVID-19U07.1
- Registration Number
- IRCT20161108030776N3
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Patients with COVID-19
Mild to moderate disease
Candidates for outpatient treatment based on the protocol of the Ministry of Health
Patients 18-65 years old
Exclusion Criteria
Patients with allergies and asthma
Patients with hypertension
Patients with diabetes
Pregnancy / lactation
Patients with heart failure
Patients with chronic renal failure
Patients undergoing chemotherapy
Patients receiving corticosteroids
Patients with immunodeficiency
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body temperature. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Mercury thermometer.;Cough (severity-frequency). Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Fiston Scale.;Weakness and lethargy. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Visual analog scale (VAS).;Body pain. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Visual analog scale (VAS).;Breathing speed. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Count the number of breaths per minute.;Diarrhea (watery stools). Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Question from the patient.
- Secondary Outcome Measures
Name Time Method Being admitted to the hospital. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: The ratio of the number of cases leading to hospitalization to the total number of patients in each group.;Death rate. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Ratio of number of deaths to total patients in each group.